Hamburg - On October 14, 2021, Berlin-based Mayd announced it has raised $15 million in seed financing to advance its medicine delivery platform.
Mayd has spied an opportunity to build out a delivery platform in Europe which partners with the small-scale pharmacies that tend to be the norm on the continent, capitalizing on how the pandemic has generally accelerated demand for on-demand delivery.
The startup, which was only founded at the beginning of the year, has bagged €13 million ($15 million) in seed funding from 468 Capital, Earlybird and Target Global to build out its vision of delivering meds to Europeans’ doors fast — within 30 minutes if they’re ordered before midnight (or the next day, at a selected slot starting from 8 a.m.).
NEUWERK advised Mayd on the transaction.
For more information, please see Mayd's press release.
Advisors for Mayd:
Kirsten Seeger (partner Corporate/M&A)
Daniel Meyer (Associate)
About NEUWERK: NEUWERK was founded in 2016 by lawyers from Freshfields Bruckhaus Deringer and ROXIN in Hamburg. NEUWERK brings together specialists from the fields of labor law, corporate law/M&A, IP/IT, real estate law, litigation and white-collar criminal law/criminal compliance.
Press contact: For further questions please contact Dr. Sebastian Naber (firstname.lastname@example.org), T +49 40 340 5757-30.
NEUWERK Rechtsanwälte PartG mbB, Gänsemarkt 35, 20354 Hamburg, Germany www.neuwerk.legal